Ghumman, S.A.; Hameed, H.; Noreen, S.; Al-Hussain, S.A.; Kausar, R.; Irfan, A.; Shabbir, R.; Rana, M.; Amanat, A.; Zaki, M.E.A.
In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder. Pharmaceuticals 2023, 16, 265.
https://doi.org/10.3390/ph16020265
AMA Style
Ghumman SA, Hameed H, Noreen S, Al-Hussain SA, Kausar R, Irfan A, Shabbir R, Rana M, Amanat A, Zaki MEA.
In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder. Pharmaceuticals. 2023; 16(2):265.
https://doi.org/10.3390/ph16020265
Chicago/Turabian Style
Ghumman, Shazia Akram, Huma Hameed, Sobia Noreen, Sami A. Al-Hussain, Rizwana Kausar, Ali Irfan, Ramla Shabbir, Maria Rana, Amina Amanat, and Magdi E. A. Zaki.
2023. "In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder" Pharmaceuticals 16, no. 2: 265.
https://doi.org/10.3390/ph16020265
APA Style
Ghumman, S. A., Hameed, H., Noreen, S., Al-Hussain, S. A., Kausar, R., Irfan, A., Shabbir, R., Rana, M., Amanat, A., & Zaki, M. E. A.
(2023). In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder. Pharmaceuticals, 16(2), 265.
https://doi.org/10.3390/ph16020265